These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3704769)

  • 1. [Effect of peripheral vasodilators on thrombocyte aggregation in chronic circulatory insufficiency].
    Kirichenko LL; Gaĭdukova NI; Solov'eva FV
    Sov Med; 1986; (2):91-4. PubMed ID: 3704769
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant therapy of chronic refractory cardiac failure with oral hydralazine and isosorbide dinitrate.
    Kothiala A; Ramnani K; Patel HR; Mehta NC; Shah CP
    J Assoc Physicians India; 1983 Jun; 31(6):343-6. PubMed ID: 6654793
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC; Chakraborty S; Mondal M; Bhandari B
    J Assoc Physicians India; 1993 May; 41(5):269-71. PubMed ID: 8300456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamic effects of oral dihydralazine and sublingual isosorbide dinitrate, alone and in combination in chronic heart failure].
    Page A; Larnaudie B; Pic A; Videau P; Besse P
    Arch Mal Coeur Vaiss; 1979 Dec; 72(12):1367-75. PubMed ID: 120154
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of peripheral vasodilators with different mechanisms of action in treating heart failure patients].
    Novikov SV; Mareev VIu; Elizarova NA; Naumov VG; Sazonova LN
    Ter Arkh; 1987; 59(9):126-30. PubMed ID: 3424177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of advanced heart failure with hydralazine and isosorbide dinitrate (author's transl)].
    Lanas F; Salvatici R; Opazo JA; Saavedra J; Iturriaga J
    Rev Med Chil; 1979 Oct; 107(10):926-30. PubMed ID: 550229
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of trekrezan on the lipid peroxidation in patients with chronic cardiac insufficiency].
    Sabadyshin RO; Slipak OIa; Koval'chuk SF; D'iakov VM; Kazimirovskaia VB
    Biull Eksp Biol Med; 1998 Aug; 126(8):186-8. PubMed ID: 9777233
    [No Abstract]   [Full Text] [Related]  

  • 9. BiDil (isosorbide dinitrate and hydralazine hydrochloride).
    Sica DA
    Congest Heart Fail; 2006; 12(2):110-1. PubMed ID: 16596047
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
    Wlazłowski R; Kruszyński G; Goch JH
    Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peripheral vasodilator in cardiac insufficiency in the acute period of myocardial infarction].
    Ruksin VV
    Sov Med; 1985; (2):54-6. PubMed ID: 3992326
    [No Abstract]   [Full Text] [Related]  

  • 12. [Peripheral vasodilators in the treatment of chronic circulatory failure in ischemic heart disease patients].
    Lipnitskiĭ TN; Sheverda MG; Otkalenko IuK; Brovko AKh; Bogdanov EA
    Vrach Delo; 1986 Aug; (8):5-8. PubMed ID: 3776159
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative evaluation of the effectiveness of various peripheral vasodilators in the treatment of cardiac insufficiency].
    Mukharliamov NM; Mareev VIu; Novikov SV; Evdokimova NKh; Ageev FT
    Ter Arkh; 1985; 57(5):89-94. PubMed ID: 3927501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution].
    Artese D; Albani A; Di Tomasso E
    Minerva Med; 1983 Mar; 74(13):715-22. PubMed ID: 6220231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic heart failure and vasodilator therapy].
    Ito T; Matsumoto S; Ito Y
    Nihon Rinsho; 1978 Nov; 36(11):3565-72. PubMed ID: 366206
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and management of chronic heart failure.
    Aguiar-Souto P; Garcia-Pavia P; Silva-Melchor L; Ortigosa FJ
    J Am Coll Cardiol; 2006 Jul; 48(1):223; author reply 224. PubMed ID: 16814680
    [No Abstract]   [Full Text] [Related]  

  • 17. [Systolic intervals in dilated heart insufficiency. Influence of vasodilator treatment].
    González-Juanatey JR; Amaro Cendón A; Vega Fernández M; Gil de la Peña M
    Med Clin (Barc); 1988 Jan; 90(3):93-6. PubMed ID: 3280894
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of vasodilators used in the therapy of heart failure on platelet aggregation.
    Pfister B; Imhof P
    Agents Actions; 1979 Jun; 9(2):217-9. PubMed ID: 474307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic use of vasodilators in the therapy of congestive cardiac insufficiency].
    Manfrin M; Frascione P; Budini A; Cesari GP; Colonna PL; Schicchi F; Chiesa R
    Minerva Med; 1982 Oct; 73(40):2741-4. PubMed ID: 7133486
    [No Abstract]   [Full Text] [Related]  

  • 20. The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.
    Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI1-4. PubMed ID: 8500232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.